Transgenic mice that overexpress the NAFLD-sensitive PNPLA3 mutant (I148M) in liver, but not in adipose tissue, express altered levels and composition of hepatic triglycerides [16]. This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.